×
App Icon
The Standard e-Paper
Truth Without Fear
★★★★ - on Play Store
Download Now

FDA approves RSV vaccine for moms-to-be to guard their newborns

Vocalize Pre-Player Loader

Audio By Vocalize

US regulators on Aug 21, 2023 approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection. [AP Photo]

US regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the respiratory infection.

RSV is notorious for filling hospitals with wheezing babies every fall and winter. The Food and Drug Administration cleared Pfizer's maternal vaccination to guard against a severe case of RSV when babies are most vulnerable - from birth through 6 months of age.

Get Full Access for Ksh299/Week.
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
By AFP 7 hrs ago
Football
Arteta urges Arsenal to seize destiny in crucial Spurs showdown
Football
Title-hungry Leopards seek to bounce back to winning ways
Golf
Magical Kenya Open: Jastas Madoya reveals what fuels his passion for golf
Olympics
NOC-K signs strategic MoU with Japanese Olympic Committee